Cargando…
New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH) is a fatal disorder with limited treatment options and reduced life expectancy after diagnosis. Complex genetic backgrounds in PAH complicates identification of causative mutations that is essential for an understanding of the disease diagnostics and etiology es...
Autores principales: | Kurdyukov, Sergey, Eccles, Cody A., Desai, Ankit A., Gonzalez-Garay, Manuel, Yuan, Jason X.-J., Garcia, Joe G. N., Rafikova, Olga, Rafikov, Ruslan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117081/ https://www.ncbi.nlm.nih.gov/pubmed/30161219 http://dx.doi.org/10.1371/journal.pone.0203493 |
Ejemplares similares
-
Antioxidant-Conjugated Peptide Attenuated Metabolic Reprogramming in Pulmonary Hypertension
por: Valuparampil Varghese, Mathews, et al.
Publicado: (2020) -
Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability
por: Rafikova, Olga, et al.
Publicado: (2020) -
Inhibition of Anaplerosis Attenuated Vascular Proliferation in Pulmonary Arterial Hypertension
por: Valuparampil Varghese, Mathews, et al.
Publicado: (2020) -
Sex-specific stress response and HMGB1 release in pulmonary endothelial cells
por: Zemskova, Marina, et al.
Publicado: (2020) -
Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex
por: RAFIKOV, RUSLAN, et al.
Publicado: (2022)